Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.


By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
via
Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year. Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year. Reviewed by news100 on 2:05 PM Rating: 5

No comments

Fashion

Fashion

Find Us on Facebook